Vaccinex, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Vaccinex, Inc. (VCNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $3.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2022-03-31
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2020-12-31 was $0.00.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2020-09-30 was $2.00K.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2020-06-30 was $0.00.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2020-03-31 was $1.00K.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $3.00K.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2018 was $11.00K, a 62.07% decline from fiscal 2017.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2017 was $29.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $2.00K derived: sum of 2 quarters · filed 2022-03-31 | $2.00K derived: sum of 3 quarters · filed 2022-03-31 | $3.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $2.00K derived: sum of 2 quarters · filed 2020-11-13 | $3.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $1.00K 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | $1.00K 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-09 | $11.00K 10-K · filed 2020-03-09 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $11.00K 10-Q · filed 2018-11-13 | ||
| 2018-06-30 | $11.00K 10-Q · filed 2018-08-14 | |||
| 2017-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $19.00K derived: sum of 2 quarters · filed 2019-03-13 | $29.00K 10-K · filed 2019-03-13 | |
| 2017-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $13.00K 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $10.00K 10-Q · filed 2018-08-14 |